(813) 345-4044 1767 S. Kings Ave., Brandon, FL
(813) 345-4044 | info@floridaaesthetics.com | Mon–Tue & Thu–Fri: 8am–5pm  ·  Wed: 10am–7pm | 1767 S. Kings Ave., Brandon, FL 33511
Weight Loss Tirzepatide at Florida Aesthetics and Wellness Brandon FL

Weight Loss · Dual GIP/GLP-1 · Brandon, FL

Tirzepatide
Dual-Action Weight Loss Program

The most effective FDA-approved weight loss medication available, a dual GIP/GLP-1 receptor agonist showing up to 21% average body weight reduction in clinical trials. A step up from semaglutide for patients who want maximum results.

Book a Free Consultation Call (813) 345-4044
FDA-Approved
for weight management (Zepbound®)
Up to 21%
average body weight lost (SURMOUNT)
Weekly Injection
Medically Supervised
About This Treatment

What is tirzepatide and how does it cause weight loss?

Reviewed by our board-certified anti-aging specialists. Medically supervised since 2006.

Tirzepatide (brand names Mounjaro® and Zepbound®) is the first dual GIP and GLP-1 receptor agonist, activating two hormonal pathways simultaneously to produce greater weight loss than GLP-1 medications alone.

GLP-1 receptor agonists like semaglutide reduce appetite and slow gastric emptying. Tirzepatide does all of that, and also activates GIP (glucose-dependent insulinotropic polypeptide) receptors, which enhances insulin secretion, reduces glucagon, and appears to amplify the total weight loss effect. In the SURMOUNT-1 clinical trial, participants on tirzepatide lost an average of 20.9% of body weight at the highest dose over 72 weeks, making it the most effective approved weight loss medication available. At Florida Aesthetics and Wellness, all tirzepatide programs are supervised by licensed medical providers with weekly check-ins to monitor progress and adjust dosing.

Who is a candidate for tirzepatide?

  • Adults with BMI ≥30 (obesity)
  • Adults with BMI ≥27 with weight-related conditions (diabetes, hypertension, dyslipidemia)
  • Patients who want maximum weight loss results
  • Those who have plateaued on semaglutide
  • Insulin resistance and pre-diabetes
  • Diet-resistant weight

Why patients choose Florida Aesthetics and Wellness for tirzepatide

  • Provider-prescribed and supervised, not a telehealth mill
  • Gradual titration starting at 2.5 mg to minimize GI side effects
  • Body composition monitoring to ensure fat loss, not muscle
  • Weekly progress check-ins and dose adjustment
  • Can transition from semaglutide if plateauing

Quick Facts

  • MedicationTirzepatide (dual GIP/GLP-1)
  • Brand namesZepbound® (weight) · Mounjaro® (diabetes)
  • FDA approvedYes, Zepbound® approved Nov 2023
  • AdministrationWeekly subcutaneous injection
  • Average weight lossUp to about 21% (SURMOUNT-1)
  • ConsultationRequired before prescribing
Tirzepatide GLP-1 weight loss treatment at Florida Aesthetics and Wellness Brandon FL
What to Expect

What to expect on your tirzepatide journey

1
Medical evaluation
Your provider reviews your health history, current medications, and weight loss goals. Lab work screens for contraindications (including thyroid history). A personalized dosing schedule is created starting at 2.5 mg weekly.
2
Starting at 2.5 mg
You begin at 2.5 mg weekly, the lowest dose, to minimize GI side effects. Most patients tolerate tirzepatide well after the first 2–4 weeks as the body adjusts.
3
Titration phase (weeks 4–20)
Dosing is gradually increased by 2.5 mg every 4 weeks toward your therapeutic target (up to 15 mg). Appetite reduction becomes pronounced. Most patients begin seeing 1–2 lbs per week loss during titration.
4
Maintenance and monitoring
Weekly in-clinic check-ins track your progress, adjust dosing if needed, and provide ongoing support. We recommend pairing tirzepatide with body composition scans to ensure you're losing fat, not muscle, and to track your metabolic changes over time.
Common Questions

Tirzepatide Weight Loss, Frequently Asked Questions

The SURMOUNT-1 trial showed average weight loss of 20.9% at the 15 mg dose over 72 weeks. At 5 mg, average loss was 15%. Some participants lost more than 25% of body weight. Tirzepatide consistently outperformed semaglutide in comparative data. Individual results vary.
The most common side effects are GI-related: nausea, diarrhea, constipation, and reduced appetite. These typically improve after the first 4–8 weeks and are minimized by slow titration starting at 2.5 mg. Your provider screens for contraindications including personal or family history of thyroid cancer (MEN2) before prescribing.
In the SURMOUNT vs. STEP clinical data, tirzepatide produced greater average weight loss than semaglutide at comparable doses. Tirzepatide activates two hormone pathways (GIP + GLP-1) vs. one (GLP-1 alone), which appears to produce an additive effect. That said, the best medication is the one that works for your body, your provider will evaluate which is most appropriate.
Yes, tirzepatide is the active ingredient in both Mounjaro® (approved for type 2 diabetes) and Zepbound® (FDA-approved in November 2023 for chronic weight management). At Florida Aesthetics and Wellness, we prescribe the weight management protocol.
Yes, many patients transition to tirzepatide after plateauing on semaglutide. Your provider will guide the transition with appropriate dosing. Tirzepatide also pairs well with B12/MIC injections (for energy and metabolism) and body composition analysis (to track fat vs. muscle changes).
Most patients come in weekly. The visit is both your injection and your check-in, so your dose, your progress, and any side effects are reviewed in person as you go. Patients who prefer to self-inject at home can be approved for that by our board-certified anti-aging specialist and come in monthly instead. In both cases your dosing and titration are approved by your provider, not set automatically.
Often Paired With

Treatments that complement Tirzepatide

Most patients benefit from at least one complementary treatment for a more complete result.

Aesthetics

Noticing Facial Changes?

Rapid weight loss can deflate the face and loosen skin. See how we restore volume and firmness naturally.

Restore your look →
Weight Loss

Semaglutide

The weekly GLP-1 injection with 15% average weight loss, a strong option if tirzepatide is not indicated.

Explore semaglutide →
Weight Loss

B12/MIC Injections

Weekly vitamin and lipotropic injections to boost energy and support fat metabolism during your program.

Explore B12/MIC injections →
Body Contouring

Body Composition Analysis

Track fat vs. muscle loss with precision, ensure you're losing fat, not muscle, during your program.

Explore body composition →

Curious about cost? Pricing depends on your specific treatment plan, which we map out at your consultation. The treatment you’re interested in might be on sale this month, so see our pricing page for current rates and check this month’s specials.

View Pricing This Month’s Specials

Clinical References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Mean body weight change of −14.9% at week 68 (STEP 1).
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Mean body weight reduction of 15.0%, 19.5% and 20.9% at 72 weeks for the 5 mg, 10 mg and 15 mg doses (SURMOUNT-1).

Trial results reflect study populations under clinical supervision alongside lifestyle intervention. Individual results vary.

Ready to Book?

Start with a complimentary consultation, no obligation

Our medical provider will evaluate your health history and determine if tirzepatide is the right program for you. Schedule your complimentary consultation.

Book a Free Consultation See This Month's Specials Call (813) 345-4044